EUVIMEDEUVIMED entdecken
Crossref

Impact of Potentized Medicines in the Management of Propylthiouracil-Induced Hypothyroidism in Mice

Gitanjali Talele, Gaurang Shah, Rajesh Shah iD

Homeopathy · 01.11.2026 · 115 (04) · 283-288

DOI: 10.1055/a-2718-5759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Homeopathy, erschienen am 01.11.2026. Verfasst von Gitanjali Talele und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biosimilia Private Limited, Department of Research, Maharashtra, India, Mumbai. Hauptthemen laut MEDLINE: Hypothyroidism, Methimazole, Somatostatin, Homeopathy. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homeopathic treatments for hypothyroidism have shown clinical efficacy in reducing dependency on levothyroxine, but there is no reported activation of thyroxine (T4) or reduction in thyroid-stimulating hormone (TSH) in animal models. In crude form, somatostatin inhibits TSH secretion, while methimazole decreases thyroid hormone synthesis. Potentized preparations of somatostatin and methimazole were examined in an animal model based on the principle of similars. Potentized preparations (30c) of somatostatin (Soma), methimazole (Mazo), and their combination were tested in the treatment of propylthiouracil-induced hypothyroidism in mice (n = 6 per group), together with vehicle, disease, and positive (thyroxine) controls. These preparations were administered orally at a daily dose of 0.1 mL for 7 to 22 days. Changes in body weight, food intake, water intake, glucose, albumin, and total proteins were monitored on days 0 and 22. Serum T3, T4 and TSH levels were measured on days 0, 7, 14 and 22. Body weight, food and water intake were not significantly altered in the groups, except the disease control group. The thyroxine-treated animals showed significant recovery in T3 levels. Similar but less prominent recovery was observed with Soma, Mazo, and the combination. Among the treatment groups, Soma (p = 0.027), Mazo (p = 0.001) and combination (p < 0.0001) showed moderate but statistically significant improvement in T4 levels. Soma (p = 0.001), Mazo (p = 0.001) and combination (p = 0.001) displayed a reduction in TSH elevation by day 22 compared with the disease control group. Serum albumin levels were similar in all groups and were not altered by any of the treatments. Serum glucose levels in disease control were significantly higher than normal control and the combination of test drugs. Potentized preparations of somatostatin and methimazole exhibited efficacy in regulating thyroid hormones in an animal model, supporting the concept of the principle of similars.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismMethimazoleSomatostatinHomeopathyAnimalsMicePropylthiouracilDisease Models, AnimalThyroxineAntithyroid AgentsThyrotropinMaleDrug Therapy, Combination

Substanzen

PropylthiouracilMethimazoleSomatostatinThyroxineAntithyroid AgentsThyrotropin

Autor:innen und Institutionen

  • Biosimilia Private Limited, Department of Research, Maharashtra, India, Mumbai.
  • LM College of Pharmacy, Department of Pharmacology, Gujarat, India, Ahmedabad.

ORCID-Profile: Rajesh Shah

Zitieren

APA

Talele, G., Shah, G., & Shah, R. (2026). Impact of Potentized Medicines in the Management of Propylthiouracil-Induced Hypothyroidism in Mice. Homeopathy, 115(04), 283-288. https://doi.org/10.1055/a-2718-5759

Vancouver

Talele G, Shah G, Shah R. Impact of Potentized Medicines in the Management of Propylthiouracil-Induced Hypothyroidism in Mice. Homeopathy. 2026;115(04):283-288. doi:10.1055/a-2718-5759

BibTeX
@article{Talele2026,
  author = {Talele, Gitanjali and Shah, Gaurang and Shah, Rajesh},
  title = {Impact of Potentized Medicines in the Management of Propylthiouracil-Induced Hypothyroidism in Mice},
  journal = {Homeopathy},
  year = {2026},
  volume = {115},
  number = {04},
  pages = {283--288},
  doi = {10.1055/a-2718-5759}
}
Kostenlos starten →